ClearPoint Neuro, Inc.

NasdaqCM:CLPT 주식 보고서

시가총액: US$147.8m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

ClearPoint Neuro 관리

관리 기준 확인 3/4

ClearPoint Neuro's CEO는 Joe Burnett, Nov2017 에 임명되었습니다 의 임기는 6.58 년입니다. 총 연간 보상은 $ 2.00M, 25.9% 로 구성됩니다. 25.9% 급여 및 74.1% 보너스(회사 주식 및 옵션 포함). 는 $ 1.31M 가치에 해당하는 회사 주식의 0.91% 직접 소유합니다. 1.31M. 경영진과 이사회의 평균 재임 기간은 각각 3.3 년과 5.7 년입니다.

주요 정보

Joe Burnett

최고 경영자

US$2.0m

총 보상

CEO 급여 비율25.9%
CEO 임기6.6yrs
CEO 소유권0.9%
경영진 평균 재임 기간3.3yrs
이사회 평균 재임 기간5.7yrs

최근 관리 업데이트

Recent updates

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

May 09
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

ClearPoint Neuro: Macro-Induced Multiple Compression

Apr 25

Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Apr 19
Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?

Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Mar 15
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report

Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Jan 04
Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Dec 06
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Nov 06
Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Aug 18
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Apr 17
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump

Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

Jan 03
Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?

ClearPoint Neuro: Continuous Great Execution

Sep 19

ClearPoint Neuro: Picks & Shovels Galore

Aug 19

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Aug 18
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro:  A 'Picks And Shovels' Biotech Company

Jul 25

ClearPoint Neuro: Continuous Execution Despite Covid Headwind

May 20

Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

Apr 25
Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?

ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides

Mar 18

ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

Jan 19
ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?

ClearPoint Neuro: Underlying Growth Potential Concealed By COVID

Jan 14

ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice

Oct 01

ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company

Aug 06

Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Jul 19
Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?

Clearpoint Neuro (CLPT) Investor Presentation - Slideshow

May 28

Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

May 27
Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation

US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

May 13
US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results

CEO 보상 분석

Joe Burnett 의 보수는 ClearPoint Neuro 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$21m

Dec 31 2023US$2mUS$518k

-US$22m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$21m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$2mUS$494k

-US$16m

Sep 30 2022n/an/a

-US$16m

Jun 30 2022n/an/a

-US$16m

Mar 31 2022n/an/a

-US$16m

Dec 31 2021US$1mUS$445k

-US$14m

Sep 30 2021n/an/a

-US$12m

Jun 30 2021n/an/a

-US$9m

Mar 31 2021n/an/a

-US$7m

Dec 31 2020US$784kUS$435k

-US$7m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$6m

Mar 31 2020n/an/a

-US$6m

Dec 31 2019US$864kUS$366k

-US$6m

Sep 30 2019n/an/a

-US$5m

Jun 30 2019n/an/a

-US$5m

Mar 31 2019n/an/a

-US$6m

Dec 31 2018US$515kUS$360k

-US$6m

Sep 30 2018n/an/a

-US$7m

Jun 30 2018n/an/a

-US$7m

Mar 31 2018n/an/a

-US$7m

Dec 31 2017US$930kUS$55k

-US$7m

보상 대 시장: Joe 의 총 보상 ($USD 2.00M )은 US 시장( $USD 680.27K ).

보상과 수익: Joe 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Joe Burnett (47 yo)

6.6yrs

테뉴어

US$1,995,337

보상

Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of ClearPoint Neuro, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical...

리더십 팀

이름위치테뉴어보상소유권
Joseph Burnett
President6.6yrsUS$2.00m0.91%
$ 1.3m
Danilo D'Alessandro
Chief Financial Officer3.4yrsUS$930.98k0.18%
$ 262.9k
Jeremy Stigall
Chief Business Officer1.4yrsUS$838.49k데이터 없음
Mazin Sabra
Chief Operating Officer1.7yrs데이터 없음0.16%
$ 236.6k
Ellisa Cholapranee
General Counsel & Secretary3.2yrs데이터 없음데이터 없음
Jacqueline Keller
Vice President of Marketing4.6yrs데이터 없음데이터 없음

3.3yrs

평균 재임 기간

41.5yo

평균 연령

경험이 풍부한 관리: CLPT 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Joseph Burnett
President6.6yrsUS$2.00m0.91%
$ 1.3m
R. Fletcher
Independent Chairman of the Board7.1yrsUS$227.62k0.34%
$ 495.6k
B. Johnson
Independent Director4.8yrsUS$189.99k0.14%
$ 202.7k
Lynnette Fallon
Independent Director2.9yrsUS$202.49k0.11%
$ 161.7k
Pascal E. Girin
Independent Director9.8yrsUS$192.65k0.26%
$ 389.1k
Linda Liau
Independent Director2.6yrsUS$182.49k0.11%
$ 163.2k
Timothy Richards
Independent Director10.3yrsUS$194.75k0.22%
$ 331.8k
Matthew Klein
Director4.2yrsUS$174.99k0.11%
$ 158.6k

5.7yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: CLPT 의 이사회는 경험(평균 재직 기간 5.7 년)으로 간주됩니다.